Involvement of nuclear factor κB in platelet CD40 signaling

Biochemical and Biophysical Research Communications

Volumn 425, Issue 1, 2012, Pages 58-63

  Hachem, Ahmed ^a   Yacoub, Daniel ^a,c   Zaid, Younes ^a   Mourad, Walid ^b,c   Merhi, Yahye ^a,b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

NF jB; P38 MAPK; Platelet, CD40L; TRAF

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; COLLAGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2;

ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HYPOTHESIS; INFLAMMATORY DISEASE; LIGATION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ANTIGENS, CD40; BLOOD PLATELETS; CD40 LIGAND; CELLS, CULTURED; HUMANS; I-KAPPA B PROTEINS; NF-KAPPA B; PHOSPHORYLATION; PLATELET ACTIVATION; PLATELET AGGREGATION; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 2;

EID: 84865186516     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.07.049     Document Type: Article

References (31)

1. Paulie S., Ehlin-Henriksson B., Mellstedt H., Koho H., Ben-Aissa H., Perlmann P. A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes. Cancer Immunol. Immunother. 1985, 20:23-28.
2. Karmann K., Hughes C.C., Schechner J., Fanslow W.C., Pober J.S. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc. Natl. Acad. Sci. USA 1995, 92:4342-4346.
3. Alderson M.R., Armitage R.J., Tough T.W., Strockbine L., Fanslow W.C., Spriggs M.K. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 1993, 178:669-674.
4. Clark E.A., Grabstein K.H., Shu G.L. Cultured human follicular dendritic cells. Growth characteristics and interactions with B lymphocytes. J. Immunol. 1992, 148:3327-3335.
5. Henn V., Slupsky J.R., Grafe M., Anagnostopoulos I., Forster R., Muller-Berghaus G., Kroczek R.A. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998, 391:591-594.
6. Arron J.R., Pewzner-Jung Y., Walsh M.C., Kobayashi T., Choi Y. Regulation of the subcellular localization of tumor necrosis factor receptor-associated factor (TRAF)2 by TRAF1 reveals mechanisms of TRAF2 signaling. J. Exp. Med. 2002, 196:923-934.
7. Xie P., Hostager B.S., Bishop G.A. Requirement for TRAF3 in signaling by LMP1 but not CD40 in B lymphocytes. J. Exp. Med. 2004, 199:661-671.
8. Bishop G.A. The multifaceted roles of TRAFs in the regulation of B-cell function. Nat. Rev. Immunol. 2004, 4:775-786.
9. Gilmore T.D. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 2006, 25:6680-6684.
10. Liu F., Morris S., Epps J., Carroll R. Demonstration of an activation regulated NF-kappaB/I-kappaBalpha complex in human platelets. Thromb. Res. 2002, 106:199-203.
11. Malaver E., Romaniuk M.A., D'Atri L.P., Pozner R.G., Negrotto S., Benzadon R., Schattner M. NF-kappaB inhibitors impair platelet activation responses. J. Thromb. Haemost. 2009, 7:1333-1343.
12. Gambaryan S., Kobsar A., Rukoyatkina N., Herterich S., Geiger J., Smolenski A., Lohmann S.M., Walter U. Thrombin and collagen induce a feedback inhibitory signaling pathway in platelets involving dissociation of the catalytic subunit of protein kinase A from an NFkappaB-IkappaB complex. J. Biol. Chem. 2010, 285:18352-18363.
13. von Hundelshausen P., Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ. Res. 2007, 100:27-40.
14. Henn V., Steinbach S., Buchner K., Presek P., Kroczek R.A. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 2001, 98:1047-1054.
15. Andre P., Nannizzi-Alaimo L., Prasad S.K., Phillips D.R. Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 2002, 106:896-899.
16. Garlichs C.D., John S., Schmeisser A., Eskafi S., Stumpf C., Karl M., Goppelt-Struebe M., Schmieder R., Daniel W.G. Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia. Circulation 2001, 104:2395-2400.
17. Heeschen C., Dimmeler S., Hamm C.W., van den Brand M.J., Boersma E., Zeiher A.M., Simoons M.L. Soluble CD40 ligand in acute coronary syndromes. N. Engl. J. Med. 2003, 348:1104-1111.
18. Sanguigni V., Pignatelli P., Lenti L., Ferro D., Bellia A., Carnevale R., Tesauro M., Sorge R., Lauro R., Violi F. Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients. Circulation 2005, 111:412-419.
19. Yacoub D., Hachem A., Theoret J.F., Gillis M.A., Mourad W., Merhi Y. Enhanced levels of soluble CD40 ligand exacerbate platelet aggregation and thrombus formation through a CD40-dependent tumor necrosis factor receptor-associated factor-2/Rac1/p38 mitogen-activated protein kinase signaling pathway. Arterioscler Thromb. Vasc. Biol. 2010, 30:2424-2433.
20. Aicher A., Shu G.L., Magaletti D., Mulvania T., Pezzutto A., Craxton A., Clark E.A. Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cells. J. Immunol. 1999, 163:5786-5795.
21. Rothe M., Sarma V., Dixit V.M., Goeddel D.V. TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40. Science 1995, 269:1424-1427.
22. Andre P., Prasad K.S., Denis C.V., He M., Papalia J.M., Hynes R.O., Phillips D.R., Wagner D.D. CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism. Nat. Med. 2002, 8:247-252.
23. Chakrabarti S., Varghese S., Vitseva O., Tanriverdi K., Freedman J.E. CD40 ligand influences platelet release of reactive oxygen intermediates. Arterioscler Thromb. Vasc. Biol. 2005, 25:2428-2434.
24. Danese S., de la Motte C., Reyes B.M., Sans M., Levine A.D., Fiocchi C. Cutting edge: T cells trigger CD40-dependent platelet activation and granular RANTES release: a novel pathway for immune response amplification. J. Immunol. 2004, 172:2011-2015.
25. Inwald D.P., McDowall A., Peters M.J., Callard R.E., Klein N.J. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ. Res. 2003, 92:1041-1048.
26. Bonizzi G., Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004, 25:280-288.
27. Craxton A., Shu G., Graves J.D., Saklatvala J., Krebs E.G., Clark E.A. P38 MAPK is required for CD40-induced gene expression and proliferation in B lymphocytes. J. Immunol. 1998, 161:3225-3236.
28. Mazharian A., Roger S., Maurice P., Berrou E., Popoff M.R., Hoylaerts M.F., Fauvel-Lafeve F., Bonnefoy A., Bryckaert M. Differential Involvement of ERK2 and p38 in platelet adhesion to collagen. J. Biol. Chem. 2005, 280:26002-26010.
29. Ma X., Becker Buscaglia L.E., Barker J.R., Li Y. MicroRNAs in NF-kappaB signaling. J. Mol. Cell Biol. 2011, 3:159-166.
30. Landry P., Plante I., Ouellet D.L., Perron M.P., Rousseau G., Provost P. Existence of a microRNA pathway in anucleate platelets. Nat. Struct. Mol. Biol. 2009, 16:961-966.
31. Suzuki K., Verma I.M. Phosphorylation of SNAP-23 by IkappaB kinase 2 regulates mast cell degranulation. Cell 2008, 134:485-495.